×

Tumor-associated peptides binding promiscuosly to human leukocyte antigen (HLA) class II molecules

  • US 7,807,642 B2
  • Filed: 11/19/2007
  • Issued: 10/05/2010
  • Est. Priority Date: 09/05/2005
  • Status: Active Grant
First Claim
Patent Images

1. An isolated tumour associated peptide comprising the peptide set forth in SEQ ID NO:

  • 2 flanked by N- and/or C-terminal extensions between 1 to 10 amino acids in length.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×